Breast cancer treatment market booming
March 19, 2015Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb
The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …
AstraZeneca and Daiichi team up for constipation drug
March 19, 2015Sales and Marketing AstraZeneca, Daiichi, Movantik, constipation, naloxegol, oic
AstraZeneca and Daiichi Sankyo have signed a deal worth around $825 million to jointly commercialise constipation drug Movantik in the …
Sanofi diabetes drug fails to show cardio disease benefit
March 19, 2015Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes
A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …
Teva and Ignyta shake hands in oncology deal
March 19, 2015Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology
Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …
MISSION hires chief business officer from Medivir
March 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medvir, mission, paul wallace
UK, Cambridge-based cancer biotech MISSION Therapeutics has appointed Dr Paul Wallace as its chief business officer. Having worked in business …
Pharma to profit from Obama reforms
March 18, 2015Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance
President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …
Valeant sprints ahead of Endo to secure Salix
March 18, 2015Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix
Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …
AstraZeneca buoyed by late-stage trial success
March 18, 2015Sales and Marketing AstraZeneca, copd. asthma, formoterol fumarate, glycopyrronium, ptoo3, respiratory
AstraZeneca’s investigational respiratory drug has posted positive results in a Phase III trial in people with COPD, having found it …
The 2015 European Life Sciences Industry Survey on Customer Data
March 18, 2015Dear Colleague, You are invited to take part in the 2015 European Life Sciences Industry Survey on Customer Data. Your …
GSK premature babies drug starts late-stage trials
March 18, 2015Sales and Marketing GSK, Retosiban, atosiban, babies, birth, oxytocin, premature
GlaxoSmithKline has initiated Phase III studies to evaluate the safety and efficacy of an investigational treatment for babies born prematurely. …
Catalent Pharma Solutions names new unit head
March 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing catalent pharma solutions, sharon johnson
UK pharma and healthcare products firm Catalent Pharma Solutions has picked its senior VP Sharon Johnson of the company’s quality …
Baxter’s haemophilia drug performs
March 17, 2015Sales and Marketing BAX 817, VIIa, baxter, haemophilia, rFVIIa
Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …
Mixed results for AstraZeneca in high-profile Brilinta study
March 17, 2015Sales and Marketing American College of Cardiology, AstraZeneca, Brilinta, EMA, FDA, ticagrelor
Experts say AstraZeneca is at risk of ‘diminishing returns’ in the clinical advantages of its blood-thinning drug Brilinta, after it …
Novartis blood cancer drug given EU nod
March 17, 2015Sales and Marketing Cancer, EU, Jakavi, Novartis, oncology, polycythemia vera, ruxolitinib
Novartis’ blood cancer drug Jakavi has been given the green light in Europe to treat adult patients with polycythemia vera …
Sanofi affiliate to supply 37 million vaccines
March 17, 2015Manufacturing and Production, Sales and Marketing GAVI, Sanofi, Sanofi Pasteur, Shantha Biotechnics, shan5, vaccines
Sanofi’s vaccines division Sanofi Pasteur has confirmed its affiliate Shantha Biotechnics in India has delivered the first 400,000 doses of …
Big pharma partners with government over $100m dementia fund
March 17, 2015Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly
Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …
23andMe assigns chief scientific officer to new unit
March 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andm3, Richard Scheller
US personal genetics firm 23andMe has created a new therapeutics group and appointed pharma veteran Richard Scheller as chief science …
23andMe to move into drug development
March 16, 2015Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, Pfizer, google
The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …
NHS is struggling to improve cancer care
March 16, 2015Sales and Marketing CRUK, Cancer, Department of Health, NHS, NHS England, oncology
The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …
Sanofi and Amgen cholesterol drugs shine
March 16, 2015Sales and Marketing Amgen, PCSK9, Repatha, Sanofi, alirocumab, evolocumab, praluent
Two large Phase III studies of Sanofi’s Praluent and Amgen’s Repatha have found the biologic cholesterol-lowering drugs are more effective …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
